A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
SillaJen, Inc.
Rigel Pharmaceuticals
Essen Biotech
Case Comprehensive Cancer Center
IGM Biosciences, Inc.
Karyopharm Therapeutics Inc
BerGenBio ASA
Stanford University
Taproot Health
Sellas Life Sciences Group
Cancer Support Community, Research and Training Institute, Philadelphia
OHSU Knight Cancer Institute
Sumitomo Pharma America, Inc.
Case Comprehensive Cancer Center
AbbVie
Hospital Universitario San Ignacio
Weprom
University of Wisconsin, Madison
Incyte Corporation
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
National Institutes of Health Clinical Center (CC)
Butler Hospital
European Organisation for Research and Treatment of Cancer - EORTC
University of Kansas Medical Center
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Novartis
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Fox Chase Cancer Center
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novacea